Literature DB >> 953987

Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A.

I J Fidler, J H Darnell, M B Budmen.   

Abstract

Macrophage-activating factor (MAF) was obtained from cultures of normal F344 rat lymphocytes incubated with insoluble concanavalin A. The MAF rendered macrophages from normal C57BL/6 mice cytotoxic against the syngeneic B16 melanoma and the allogeneic AC 15091. At the same time, normal syngeneic or allogeneic embryo cells were unharmed, even in the presence of susceptible tumor cells. Optimal MAF levels followed incubation of lymphocytes for 48 hr with Sepharose-bound concanavalin A. A 2-hr incubation of macrophages with MAF was sufficient to initiate activation, providing that 46 hr were allowed to elapse before tumor cells were added. The MAF activity was enhanced after heating the supernatant to 199 degrees. Control experiments largely excluded the possibility that residual unbound concanavalin A caused the observed macrophage-mediated tumoricidal effects.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 953987

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Production of macrophage activation factors by tryptic cleavage of calf serum proteins.

Authors:  M C McDaniel; M A Tucker; D A Johnson
Journal:  Inflammation       Date:  1983-12       Impact factor: 4.092

Review 2.  Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.

Authors:  I J Fidler; G Poste
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Kinetics and ultrastructural studies of the induction of rat alveolar macrophage fusion by mediators released from mitogen-stimulated lymphocytes.

Authors:  S Sone; C Bucana; L C Hoyer; I J Fidler
Journal:  Am J Pathol       Date:  1981-05       Impact factor: 4.307

4.  Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.

Authors:  Gabriella K Brown; Cesar Tovar; Anne A Cooray; Alexandre Kreiss; Jocelyn Darby; James M Murphy; Lynn M Corcoran; Silvana S Bettiol; A Bruce Lyons; Gregory M Woods
Journal:  Immunol Cell Biol       Date:  2016-04-19       Impact factor: 5.126

5.  7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine.

Authors:  B L Pope; J Sigindere; E Chourmouzis; P MacIntyre; M G Goodman
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

6.  Thioglycolate medium decreases resistance to bacterial infection in mice.

Authors:  L A Baker; P A Campbell
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

7.  High dietary vitamin A (retinyl palmitate) and cellular immune functions in mice.

Authors:  S Moriguchi; L Werner; R R Watson
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

8.  Successful immunotherapy of murine melanoma metastases with 7-thia-8-oxoguanosine.

Authors:  B S Sharma; L Balazs; A Jin; W B Jolley; R K Robins
Journal:  Clin Exp Metastasis       Date:  1991 Sep-Oct       Impact factor: 5.150

9.  Activation of mouse peritoneal macrophages by synthetic glyceroglycolipid liposomes.

Authors:  M Naito; I Kudo; Y Mukai-Sato; S Tsushima; H Nomura; S Nojima; K Inoue
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.

Authors:  E S Kleinerman; A J Schroit; W E Fogler; I J Fidler
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.